Drug Discovery

San Diego skyline
#AI / data analytics / healthtech / informatics #Data automation #Drug discovery #Events #Life sciences #SLAS2023

SLAS2023 is ready for you

Ahead of SLAS2023 in San Diego, Jill Hronek, SLAS Director, Marketing & Communications, shares her enthusiasm for the opportunities, products, technologies and innovation that this event brings together. Data is the glue that keeps automation tools working together. We’re accelerating into another year of innovation and automation at SLAS: our… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Event: How to choose the most promising drug candidates

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#Automated workflows #Automation #Automation / robotics #Biopharma #Biopharmaceuticals #Lab automation #Lab technology #Personalised medicine

The push towards lab automation in biopharma

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong speaks to Peter Walters, Director Advanced Therapies, CRB, and Grace Linton, Director Process Architecture, CRB about automation within laboratory settings and its effect on the pharmaceutical industry. RA: How are labs utilising automated systems in… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Drug discovery #Events #SLAS2023

SLAS2023: We have the building blocks, onto the building

By DDW Multimedia Editor Megan Thomas. In the time that has passed since SLAS2022 in Boston, USA, the drug discovery industry has had to deal with all manner of external obstacles, from the war in Ukraine, to how Brexit has changed the world’s relationship with the UK, and the post-Covid-19… Read More

#Exclusive Content

#Drug discovery #Genetics / genomics #Interview #Precision medicine #RNA #RNA sequencing #Transcriptomics

How transcriptomics is driving drug discovery

Listen to this article on the DDW Podcast: Dr Stephen Barat, Senior Vice President and Therapeutics Division Head at HTG Molecular Diagnostics tells DDW how transcriptomics is driving drug discovery and precision medicines. DDW: Could you explain the process of transcriptomics?  SB: Transcriptomics is the study… Read More

#Exclusive Content

#Cell and gene therapy #Drug development #Drug discovery #Webinar

Webinar: Opportunities for CGT in drug development

Hosted by DDW and supported by Benchling and BPS Bioscience, Cell and gene therapy: sustaining growth and maximising opportunities will be free to attend on February 17 at 8am PST / 11am EST / 4pm GMT / 5pm CET. Cell and gene therapies (CGT) are transforming the way diseases… Read More

#News

#Breast cancer #Cancer research #Clinical trial design #Clinical trials #Drug development #Drug discovery #Oncology #Phase III trial

This week in drug discovery (6-10 February)

News round-up for 6-10 February by DDW Digital Content Editor Diana Spencer.  Clinical drug trials have made the headlines this week, as it was revealed that breast cancer still tops the bill for number of clinical studies and the shortcomings in current methods to ensure representation of patient… Read More

#News

Scandinavia
#Drug development #Drug discovery #Life sciences #Market reporting #Scandinavia #Sweden

Scandinavia: insight into opportunities for drug discovery

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. Though not without its challenges, the life sciences industry in Scandinavia… Read More

#Exclusive Content #Market Reports

Nanoscale virus
#AstraZeneca #CAMECA #Drug discovery #Molecular medicine #Nanomedicine / nanotechnology

Nano technique reveals how drug molecules behave in cells

Researchers have made it possible to see at the nano level where a medicinal drug ends up in the cells and how much of it is needed for optimum treatment.  The technique enables the development of new pharmaceuticals and tailored treatments for diseases that have not previously… Read More

#Editor's Choice #News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Data science #Drug development #Drug discovery #Pharmaceuticals

AI is critical to solving new complexities in drug discovery

Listen to this article on the DDW Podcast: Andrew A Radin Chief Executive Officer of Aria Pharmaceuticals, on the critical use of artificial intelligence in solving some of drug discovery’s most new and complex challenges. Basic research and new technologies are uncovering insights every day that build on… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Learn how to choose the best drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AAV #Cell and gene therapy #Drug development #Drug discovery #Gene therapy #Immunology / Virology & Vaccines

Optimising AAV capsid purification through improved analytics

Listen to this article on the DDW Podcast: Svea Cheeseman, Refeyn, explains why better efficiency is needed to advance the production of viral vectors for use in gene therapies. Adeno-associated viruses (AAVs) are a promising, widely used vector for delivering gene therapies. As demand for AAV gene… Read More

#Exclusive Content

#Advanced Therapies #Cell and gene therapy #Cell culture #Drug development #Drug discovery #Whitepaper

Whitepaper: From bench to billions in cell and gene therapy

Download our new whitepaper ‘From bench to billions: A guide to facilitating scale-up of adherent cultures for cell and gene therapies’, brought you by Corning. Given the potential of emerging advanced therapies, market demand is likely to continue to grow. Generating the required quantity of cells efficiently becomes even more… Read More

#News

#Advanced Therapies #Cell and gene therapy #Cell culture #Drug development #Drug discovery

From bench to billions: A guide to facilitating scale-up of adherent cultures for cell and gene therapies

Given the potential of emerging advanced therapies, market demand is likely to continue to grow. Generating the required quantity of cells efficiently becomes even more challenging when the cells of interest are attachment-dependent, such as induced pluripotent stem cells (iPSCs). The choice of cell culture platform will have significant operational… Read More

#Resources

ChatGPT
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Computational chemistry #Drug development #Drug discovery #Drug targets #Regulatory #Technology

Four ways ChatGPT could impact drug discovery

It’s impossible to be online and not hear about ChatGPT, the controversial chatbot launched by OpenAI in November 2022. Here, DDW’s Diana Spencer takes a look at the ways ChatGPT and technology like it could change the future of drug discovery and development. Chat Generative Pre-Trained Transformer (or ChatGPT) is… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Bioinformatics #Drug development #Drug discovery #Emmes #Omics #Personalised medicine #Systems biology

How big data analytics can make personalised care a reality

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. A key breakthrough area where big data analytics has shown tremendous scope and application is… Read More

#Exclusive Content #Opinion